[quote]Did you see the article last week about one of the big investors in Amylin urging for the company to be sold off?[/quote]
I think that is what Amylin is doing by cost-cutting and trying to become profitable. The big hit they just took is mostly on their followon drug needing more trials due to manufacturing issues. They must conserve cash to run the trials. I bet if there is a second wave it is including research but that is just a hunch.
Don’t listen to what Carl Icahn says though. He bought into Yahoo for the MSFT buyout and lost big on that one.
